Description
Join Sunstone Therapies CEO and Co-founder, Dr. Manish Agrawal, and Therapist Program Director, Rachel Winzer, as they share insights from Sunstone's work conducting psychedelic therapy research over the last four years. This webinar will provide an overview of our clinical research findings across multiple psychedelics and mental health challenges, and address the complexities of scaling psychedelic therapy. Additionally, the discussion will explore the challenges of training therapists to deliver this unique form of care and the critical importance of proper therapist training to ensure safety and efficacy.
Instructor
Rachel brings experience in mental health care across clinical research, therapist training and assessment, therapy optimization, and clinical care to her role as the Director of the Therapist Program at Sunstone Therapies. Rachel previously held the position of Senior Manager of Clinical Innovation at COMPASS Pathways where she worked to build and scale all therapist programming for psilocybin therapy research. Prior to COMPASS Rachel worked in direct patient care in clinical settings in Massachusetts, as a mental health specialist and training supervisor at the McLean Franciscan Child and Adolescent Inpatient Psychiatric Unit, and prior to that as a behavioral treatment counselor and supervisor at the Youth Villages-Germaine Lawrence group and residential home, serving adolescents with complex behavioral, psychological and learning needs. Rachel holds a Master's in Social Cognition from University College London and a Bachelor's in Psychology from the University of Colorado.
Dr. Manish Agrawal’s extensive background and experience spans medicine, engineering, philosophy, ethics, and research. He currently serves as Founder & CEO of Sunstone Therapies, a leader in the delivery of psychedelic-assisted therapy in the medical setting and the development and execution of clinical trials for those affected by complex mental health challenges. Manish previously held the position of Co-Director of Clinical Research at Maryland Oncology Hematology, where he dedicated 18 years to the care of cancer patients. He completed a fellowship at the National Cancer Institute, National Institutes of Health, and his residency at Georgetown University Medical Center.
Learning Objectives
By the end of this workshop, participants will be able to:
-
Present key findings from at least five recent clinical trials, including patient demographics and outcomes, in a 15-minute group presentation.
-
Describe at least three challenges in therapist training, supported by current literature, and share this outline in a 10-minute presentation.
-
List four major obstacles to scaling psychedelic therapy and propose at least two actionable solutions for each.
Bibliography & References
BIBLIOGRAPHY & REFERENCES
Target Audience
Social Workers, LCPCs, and Psychologists
We welcome anyone interested in the topic!
Late Fees and Refunds
The base price is $30, which includes CE credit.
Cancellations: **ALL cancellations will be subjected to a $35.00 administration fee.** Cancellations must be received 24 hours in advance prior to the workshop to receive a refund or an account credit.
ADA Accommodations
If you are requesting ADA accommodations, please contact our office via email at least two weeks prior to the workshop date. Requests after that date may not be fulfilled.
Our email address is cpe@ssw.umaryland.edu.
